GC Biopharma Corp. (KRX:006280)
119,600
+200 (0.17%)
Apr 18, 2025, 3:30 PM KST
GC Biopharma Revenue
In the year 2024, GC Biopharma had annual revenue of 1.68T KRW with 3.27% growth. GC Biopharma had revenue of 440.85B in the quarter ending December 31, 2024, with 8.87% growth.
Revenue
1,679.89B
Revenue Growth
+3.27%
P/S Ratio
0.81
Revenue / Employee
836.18M
Employees
2,009
Market Cap
1,365.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,679.89B | 53.25B | 3.27% |
Dec 31, 2023 | 1,626.64B | -84.67B | -4.95% |
Dec 31, 2022 | 1,711.31B | 173.49B | 11.28% |
Dec 31, 2021 | 1,537.83B | 33.71B | 2.24% |
Dec 31, 2020 | 1,504.12B | 147.00B | 10.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
PharmaResearch | 350.12B |